Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
Department of Physiology, Faculty of Medicine, Cairo University, Cairo, Egypt.
Biomed Pharmacother. 2023 Oct;166:115309. doi: 10.1016/j.biopha.2023.115309. Epub 2023 Aug 11.
Osteoarthritis (OA) is a common debilitating degenerative disease of the elderly. We aimed to study the therapeutic effects of combining curcumin and swimming in monosodium iodoacetate (MIA)-induced OA in a rat model. The rats were divided into 5 groups (n = 9). Group 1 received saline and served as a control group. Groups 2-5 were injected intra-articularly in the right knee with 100 μL MIA. One week later, groups 3 and 5 were started on daily swimming sessions that gradually increased to 20-mins per session, and for groups 4 and 5, oral curcumin was administered at a dose of 200 mg/kg for 4 weeks. The combination therapy (curcumin + swimming) showed the most effective results in alleviating pain and joint stiffness as well as improving histological and radiological osteoarthritis manifestations in the knee joints. The combination modality also reduced serum C-reactive protein and tissue cartilage oligomeric matrix protein levels. Mechanistically, rats received dual treatment exhibited restoration of miR-130a and HDAC3 expression. The dual treatment also upregulated PPAR-γ alongside downregulation of NF-κB and its inflammatory cytokine targets TNF-α and IL-1β. Additionally, there was downregulation of MMP1 and MMP13 in the treated rats. In conclusion, our data showed that there is a therapeutic potential for combining curcumin with swimming in OA, which is attributed, at least in part, to the modulation of miR-130a/HDAC3/PPAR-γ signaling axis.
骨关节炎(OA)是一种常见的老年人致残退行性疾病。我们旨在研究姜黄素和游泳相结合在单碘乙酸盐(MIA)诱导的 OA 大鼠模型中的治疗效果。将大鼠分为 5 组(n=9)。第 1 组接受生理盐水,作为对照组。第 2-5 组在右膝关节内注射 100 μL MIA。1 周后,第 3 组和第 5 组开始每天游泳,逐渐增加到 20 分钟/次,第 4 组和第 5 组给予姜黄素 200mg/kg 口服 4 周。联合治疗(姜黄素+游泳)在缓解疼痛和关节僵硬以及改善膝关节骨关节炎的组织学和影像学表现方面效果最显著。联合治疗还降低了血清 C 反应蛋白和组织软骨寡聚基质蛋白水平。从机制上讲,接受双重治疗的大鼠表现出 miR-130a 和 HDAC3 表达的恢复。双重治疗还上调了 PPAR-γ,同时下调了 NF-κB 及其炎症细胞因子靶点 TNF-α和 IL-1β。此外,治疗大鼠的 MMP1 和 MMP13 表达下调。总之,我们的数据表明,姜黄素和游泳联合治疗 OA 具有治疗潜力,至少部分归因于 miR-130a/HDAC3/PPAR-γ 信号通路的调节。
Biomed Pharmacother. 2023-10
BMC Complement Altern Med. 2019-11-21
Comb Chem High Throughput Screen. 2022
Front Med (Lausanne). 2025-7-2
Front Pharmacol. 2025-6-24
Inflammopharmacology. 2025-5-3
Biology (Basel). 2025-1-14
Pharmaceuticals (Basel). 2024-12-11
Biomol Biomed. 2025-3-7
Int J Mol Sci. 2024-10-30
Pharmaceuticals (Basel). 2023-1-21
Front Physiol. 2022-10-14
Front Aging Neurosci. 2022-5-3